Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Excretion of Rivaroxaban in Human Breast Milk

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06831474
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:34.757471+00:00
Published At
2025-07-17T00:00:00+00:00
Record Updated At
2025-07-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Postpartum", "VTE Prophylaxis", "VTE (Venous Thromboembolism)", "Rivaroxaban", "Breastfeeding", "Breast Milk Collection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-17"
protocolSection.identificationModule.nctId
"NCT06831474"
protocolSection.identificationModule.officialTitle
"Excretion of Rivaroxaban in Human Breast Milk"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Postpartum (protocolSection.conditionsModule.conditions)
  • VTE Prophylaxis (protocolSection.conditionsModule.conditions)
  • VTE (Venous Thromboembolism) (protocolSection.conditionsModule.conditions)
  • Rivaroxaban (protocolSection.conditionsModule.conditions)
  • Breastfeeding (protocolSection.conditionsModule.conditions)
  • Breast Milk Collection (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.